Elan Corporation, plc ELN shares are soaring this morning on rumors that Biogen Idec BIIB may bid for the company.
Just the other day, Biogen said that it would be looking for deals to expand its portfolio of multiple sclerosis drugs, and Biogen has partnered with Elan on an MS drug before, Tysabri.
At last check, shares of Elan were up 56 cents to $10.22 in pre-market trading, a gain of 5.80%.
Shares of Biogen closed at $92.80 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in